Kesios Therapeutics

Small molecule drugs for haematological malignancies, such as multiple myeloma

placeLondon, England, United Kingdom calendar_todayFounded 2012 groups1 employees language kesios.com

Registered entities

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital225%
Accelerator & incubator113%
Other / undisclosed563%
Coming soon